Silver Spring regenerative medicine firm Elutia regains Nasdaq compliance as business prospects brighten

Silver Spring regenerative medicine company Elutia Inc. (NASDAQ: ELUT) has regained compliance with the Nasdaq after teetering on the edge of a delisting, thanks to a recent uptick in its stock price. The firm, formerly called Aziyo Biologics, was able to maintain its spot on the exchange after its market value climbed to and stayed above $35 million for 10 consecutive trading days, according to a Dec. 27 Securities and Exchange Commission filing.